
We will promptly coordinate a doctor consultation and medical treatment in Israel.
Tel / Whatsapp / Viber +972 54 803 45 32 info@resultmed.com
!מבקרים באתר היקרים, אנא שימו לב
.אנחנו חברה תיירות מרפא. אנו נותנים שרות פרטי לתיירים בלבד
2018 has shown progress in treatment of five rare complex oncological diseases. These year achievements were reported in the annual Journal Clinical Cancer Advances, the print publication of the American Society of Clinical Oncology (ASCO), as well as in the Journal of Clinical Oncology in January 2019.
There was a following treatment for several rare cancers in 2018:
In 2018, FDA approved a new ATC therapy against anaplastic thyroid cancer, expanding the prescription for using the drugs combination – dabrafenib (Tafinlar) and trametinib (Mekinist). As a treatment result with the drugs combination – in more than two thirds of patients tumor stops developing and shrinks.
The drug sorafenib (Nexavar) in patients with desmoidal tumor improves survival without disease progression.
The drug Lu-dotatate received FDA approval for the patients treatment suffering from neuroendocrine midgut tumors. The drug effect is to transfer the radioactive Lutetium-177 dose directly into the tumor cells, which causes its growth to be suppressed. As international research has shown, therapy reduced disease progression and mortality by 79%, compared with standard treatment with octreotide or somatostatin.
Trastuzamab (Herceptin) which is widely used today for breast cancer treatment and stomach cancer is also effective against aggressive uterine cancer – serous cancer. This immunotherapy drug slows the progression of uterine serous cancer.
The experimental drug pexidartinib is an cell growth factor inhibitor involved in the tumor progression of tenosynovial giant cell or nodular tenosynovitis. Pexidartinib showed a positive response in a phase III study in nearly 40% of patients. All patients with a positive response showed no the disease progression according to the median observation and after 6 months.
In addition to these innovative methods, other advances in cancer treatment are also reported:
The report of the American Society of Clinical Oncology also includes a list of areas for improvement:
According to Dr. Shilski, ASCO head, the list of these items reflects the desire to find innovative methods of treating various cancer types, both for therapy and for improving the patients’ life quality.
Source: E-Med, 06/02/2019
!מבקרים באתר היקרים, אנא שימו לב
.אנחנו חברה תיירות מרפא. אנו נותנים שרות פרטי לתיירים בלבד